
Asia’s biggest drugmaker Takeda has named GlaxoSmithKline’s Christophe Weber as the leading candidate for the role of its next chief …

What has happened to the science in clinical research? Well, it is still there, but with the explosion in the …
MHP Communications has announced the appointment of a number of senior and mid-level hires to increase its health practice. Paul …
The US Food and Drug Administration has banned imports of medicines made at Wockhardt’s Chikalthana plant in India that failed …

UK healthcare group BTG has received approval from the FDA for a new type of varicose vein treatment to be …

GlaxoSmithKline is being accused of using ‘sledgehammer’ tactics by marketing agencies promoting its products after the firm allegedly demanded cash …

Contract research organisation ICON has appointed Manuel Ploch to be its general manager in Japan. Ploch will lead all of …

Boehringer Ingelheim’s hepatitis C candidate faldaprevir has moved a potential step closer to market with the news that the European …

In a blow for Pfizer NICE has categorically rejected the manufacturer’s Bosulif as a treatment for previously-treated chronic myeloid leukaemia …

The author of a damning report into failings at the Staffordshire hospital has become the new president of the Patients …

Life science talent management firm PiR Resourcing has appointed industry veteran Perry Evans to be its Client Services director. PiR …

The winners of a £2 million government competition to produce apps which will help combat alcohol abuse and weight gain …

Sanofi and partner Merrimack have posted yet more disappointing results for their investigational cancer medicine MM-121. In the latest study …

An undisclosed price cut from Novartis has been enough to swing NICE towards using the manufacturer’s Lucentis in a fourth …
Bayer HealthCare is in the market to buy Norwegian oncology specialist Algeta. The German pharma group has made a bid …

Contract development and manufacturing organisation Aesica has appointed Catherine Dick to the role of site manufacturing manager. She will take …

Gilead Sciences has run into heavy traffic in India as campaigners attempt to block the company’s patent there on new …

The Google-backed DNA testing firm 23andMe has received a warning letter from the FDA saying it cannot continue to market …